Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid for Blood Loss Reduction in Hip Fracture Patients
NCT03211286Phase 4Completed
- Start
- Jan 2018
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tranexamic acid in anemia (2 arms). Primary endpoint: Blood transfusion rate at 4 days. Started Jan 2018; status: completed.
02
Drugs
tranexamic acid
03
Conditions
anemia
Beyond the preview
Go deeper on NCT03211286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03211286.